Sign in
Not yet taking people in United StatesNo phase

Tests whole fruit effects on blood sugar in type 2 diabetes

Tests eating whole fruit in adults with type 2 diabetes not using insulin.

Key facts

Who runs it
Harvard School of Public Health (HSPH)
Where
Boston, United StatesSee the site
Trial code
Registry title
Effects of Whole Fruit on Blood Sugar in People With Type 2 Diabetes
Status
Not yet recruiting
People taking part
25 people, planned
Started
Sept 2026
Expected to end
Apr 2028
Type of study
Interventional
Treatments tested
  • Whole Fruit
Record updated
7 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who do not take insulin, to study the effects of eating whole fruit on blood sugar, liver fat and heart health.

Age
18 years or older
Sex
All sexes
Disease stage
Type 2 diabetes with HbA1c between 6.5-12.0% (48–108 mmol/mol) and fasting C-peptide level of at least 0.5 ng/ml (no beta-cell failure).
Earlier treatment
Cannot be on insulin or weight loss medication, including GLP-1 receptor agonists (e.g., semaglutide, dulaglutide). No change in dose of a long-term medication that may affect the results in the past 3 months.
Biomarker or test result
HbA1c between 6.5-12.0% (48–108 mmol/mol); fasting C-peptide level of at least 0.5 ng/ml.

Main reasons for not taking part

  • On insulin
  • Latent autoimmune diabetes (LADA) or maturity-onset diabetes of the young (MODY)
  • eGFR below 45 ml/min per 1.73 m²
  • Heart attack in the past 6 months or severe/unstable heart failure
  • Pregnant, planning pregnancy in the next 6 months, or breastfeeding

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Aged ≥18 years
  • Diagnosed with type 2 diabetes
  • HbA1c between 6.5-12.0%
  • Fasting C-peptide level ≥0.5 ng/ml, indicating the patient does not have beta-cell failure, as measured at screening

Who cannot take part

  • On weight loss medication, including GLP-1 receptor agonists (e.g., semaglutide, dulaglutide)
  • Change in the dosage of a chronic medication that may affect study endpoints within the past 3 months
  • Evidence of latent autoimmune diabetes (LADA) or maturity-onset diabetes of the young (MODY)
  • Heart attack in the past 6 months or severe/unstable heart failure
  • Significant gastrointestinal disease, major gastrointestinal surgery, or gallstones
  • Significant cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that might compromise participant safety or data validity
  • Evidence of cancer (other than non-melanoma skin cancer) within the last 5 years
  • Major psychiatric condition that would affect the ability to participate in the study
  • Not able to eat the provided study meals (e.g., food allergies)
  • Estimated glomerular filtration rate (eGFR) <45 ml/min per 1.73 m²
  • Clinically significant laboratory abnormality (e.g., abnormal hemoglobin levels)
  • On insulin
  • Lost or gained more than 5 lbs (or more than 2% of body weight if the patient weighs >250 lbs) of weight in the past 2 months
  • Pregnant, planning to become pregnant in the next 6 months, or breastfeeding
  • Behavioral factors or circumstances that may impede adherence to the dietary intervention
  • Not able to undergo the MRI scan (e.g., due to claustrophobia, implanted metal objects, or body girth ≥60 cm)

Where in United States

  • Harvard T.H. Chan School of Public HealthBoston, United StatesContact: Kathleen JohnsonNot yet recruiting

About the trial

What the trial wants to find out

This study will determine the effects of consuming whole fruit on blood sugar control, liver fat, and cardiovascular health in adults with type 2 diabetes who are not treated with insulin.

The group in the trial

  • Whole FruitTreatment being tested

    Participants will consume a large amount of whole fruit, constituting 50% of total calories.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effects of Whole Fruit on Glycemic Control, Liver Fat, and Cardiovascular Disease Risk Factors in Adults With Type 2 Diabetes
Plain-language title
Tests whole fruit effects on blood sugar in type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 July 2026